Related Experiment Videos
Outcome measures in psoriatic arthritis
Arthur Kavanaugh1, Sarah Cassell
1Division of Rheumatology, Allergy, and Immunology, University of California San Diego, 9500 Gilman Drive, La Jolla, CA 92093-0943, USA. akavanaugh@ucsd.edu
Current Rheumatology Reports
|May 28, 2005
Summary
Psoriatic arthritis (PsA) requires standardized outcome measures for assessing disease activity and treatment response. Further research is needed to develop PsA-specific measures due to its complex nature.
Area of Science:
- Rheumatology
- Clinical Trial Design
- Outcome Measurement
Background:
- Psoriatic arthritis (PsA) significantly impacts patients' lives.
- Novel therapeutics for PsA are emerging, increasing clinical trial and care interest.
- Accurate assessment of PsA disease activity and treatment response is crucial.
Purpose of the Study:
- To highlight the need for standardized outcome measures in psoriatic arthritis.
- To address the challenges in defining outcome measures for this heterogeneous condition.
- To emphasize the necessity of PsA-specific outcome measures.
Main Methods:
- Review of current outcome measures used in psoriatic arthritis.
- Analysis of the challenges associated with PsA's multifaceted nature in outcome assessment.
- Identification of the need for PsA-specific measure development.
Main Results:
- Existing outcome measures for PsA are often adapted from other diseases.
- The heterogeneity and complexity of PsA pose challenges for standardized assessment.
- There is a significant gap in PsA-specific outcome measures.
Conclusions:
- Standardized outcome measures are essential for evaluating psoriatic arthritis.
- Current measures adapted from other conditions may not fully capture PsA's complexity.
- Further research is required to delineate and validate PsA-specific outcome measures.